Dr. Francis Collins has not shown any pro-life leadership at the National Institutes of Health (NIH). In fact, in an interview, Dr. Collins response to a congressional letter outlining pro-life members concerns dripped with condescension, implying that the group of 41 congressmen understood neither the science nor the ethics of embryo and stem cell experiments. Dr. Collins owes us an apology. We know the science, use the scientifically accurate terms and know the ethical facts. Dr. Collins positions at NIH have not been pro-life.
His lack of pro-life leadership might have been expected when he served under the previous administration, which was the antithesis of pro-life. However, now Dr. Collins has agreed to work for President Trump, who campaigned on a pro-life agenda. Will Dr. Collins change his positions and adjust his agenda? When will we have a pro-life NIH Director who reflects the policy of our president?
As one example of the void in pro-life leadership, Dr. Collins designed and oversees the NIH registry of human embryonic stem cell lines, a listing of cells created by destroying young human embryos that are eligible for hundreds of millions in federal taxpayer dollars. Dr. Collins continuously approves cells for this registry, and did so most recently in March and again in June of this year.
The registry has created a cottage industry for those who want to destroy human embryos and then reap taxpayer dollars for their efforts. The establishment of the registry created an incentive for further destruction of young human embryos, under the guise of expanding scientific research and providing more experimental material. Dr. Collins called it important, life-saving research, despite the fact that embryonic stem cells have to this day not saved a single human life nor proven to have any near-term success in patients.
Eight years after its inception, the registry is nothing more than an embryonic charnel house. The stem cell lines sit as names and numbers on the registry, memorial markers to the lives of the human embryos destroyed in the name of science.
Moreover, scientific leaders admit that human embryonic stem cells now serve primarily as references to compare with nonembryonic stem cells in the laboratory. Induced pluripotent stem (iPS) cells, which show the same characteristics as embryonic stem cells, have largely replaced embryonic stem cells. The Nobel-prize-winning iPS cells can be made from virtually any person or tissue, healthy or diseased, more cheaply and efficiently than embryonic stem cells, without destroying the donor of the cells.
After consuming a decade and a half of federal funding, amounting to well over a billion taxpayer dollars, embryonic stem cell research has produced no help for patients. The stem cell registry at NIH and federal funding for it should be foreclosed, and the funds should be redirected to research that shows real hope for patients.
Click here to sign up for pro-life news alerts from LifeNews.com
In previous interviews, Dr. Collins has ignored the gold standard of stem cells for patients: adult stem cell research. Adult stem cells have now treated well over 1 million patients around the globe, including tens of thousands of children. Adult stem cells are the only stem cell option to show authenticated, life-saving success in patients, validated by hundreds of scientific publications.
Yet in a 2009 interview, Dr. Collins touted the one clinical trial approved by the FDA at the time a single trial that showed no benefit to any patient from embryonic stem cells, even to today and ignored over 2,000 adult stem cell clinical trials ongoing at the time (the number of adult stem cell trials now exceeds 3,000). Adult stem cell research is providing real innovation for patients now, and it could use the funding that now goes to dogmatic support for antiquated science. Will Dr. Collins voice his support for adult stem cell research and redirect funding toward patient-focused science.
The House of Representatives has shown tangible support for this idea with the introduction of H.R. 2918, the Patients First Act of 2017. The bill would direct HHS to prioritize adult stem cell research that has the best chance of producing near-term benefits in patients without the creation, destruction, or risk of injury to human embryos. Furthermore, the bill advocates for the ethical approach without authorizing any additional spending.
In addition to refusing to acknowledge the potential of adult stem cell research, Dr. Collins has also supported human cloning to create embryos for experiments. In this scenario, a cloned human embryo would not be allowed to survive and develop, but rather be torn apart for the use of its cells in laboratory tests. Cloning (technically termed somatic cell nuclear transfer) requires the transfer of a cell nucleus into an egg that has had its own nucleus removed. This is the way Dolly the cloned sheep and other cloned animals all began, as cloned embryos.
Yet Dr. Collins takes the unscientific view that a cloned embryo is not really an embryo, because, he says, it was not produced by a sperm and egg coming together. Even the NIH states that the cloning process produces an embryo.
The NIH can be a world leader in successful, ethical science and medicine. But this shift requires a pro-life leader at the helm.
See the article here:
Embryonic Stem Cell Research Still Hasn't Cured a Single ...
- Stem Cell Therapy Market by Treatment,Application,End Users and Geography Forecast To 2026 - Markets Gazette 24 - November 11th, 2019
- Global Stem Cell Assay Market 2019 Size, Share, Growth, Trends, Type, Application, Analysis and Forecast by 2026 - Markets Gazette 24 - November 11th, 2019
- Oct4, Considered Vital for Creating iPSCs, Actually Isnt Needed - The Scientist - November 8th, 2019
- A winding romp through advances in cell biology pushes readers to ponder the boundaries of life - Science Magazine - October 31st, 2019
- Cell Banking Outsourcing Market to 2027 - Global Analysis and Forecasts By Product Type (Cord Cell Banking, Adult Stem Cell Banking, Embryonic Stem... - October 31st, 2019
- Cell Isolation Market ||Becton, Dickinson, and Company, Thermo Fisher Scientific, Inc., Merck KGaA - Industry News Info - October 31st, 2019
- Scientists Made Mice Live 12% Longer by Hacking Their Telomeres - Futurism - October 22nd, 2019
- Scientists extend mice lifespan 12% by tweaking telomeres - Big Think - October 22nd, 2019
- Merck KGaA opens Shanghai Innovation Center and invests $ 14 million in the China Seed Fund - asume tech - October 19th, 2019
- Health policy will be the focus of the HLTH - asume tech - October 19th, 2019
- Syros sees strategic shift after the failure of the previously promising cancer drug - asume tech - October 19th, 2019
- What Theranos Whistleblowers Learn About Ethics in Health Startups - asume tech - October 19th, 2019
- Assessments of Treatment Options for Age-related Macular Degeneration - DocWire News - October 15th, 2019
- Stem Cells Market Growth Rate, Production Volume and Future Opportunities From 2019-2024 - Exponent Online - October 15th, 2019
- Catholics more motivated to donate if ethical investing is assured - Crux: Covering all things Catholic - October 10th, 2019
- Greenwood to step down as CEO of BIO after 2020 election - FierceBiotech - October 10th, 2019
- Epigenetic initiation of the TH17 differentiation program is promoted by Cxxc finger protein 1 - Science Advances - October 10th, 2019
- Interview with Tamer Mohamed of Aspect Biosystems on Advancing Tissue Therapeutics - 3DPrint.com - October 10th, 2019
- Yale researchers develop way to help brain organoids thrive - Yale News - October 9th, 2019
- Catholics more motivated to donate if ethical investing is assured - The Catholic Spirit - October 9th, 2019
- Stem Cell Market: By Key Players, Market Competitive Landscape, Trends and Forecasts to 2024 - Joliet Observer - October 9th, 2019
- Stem Cell Therapy Market to Witness a Pronounce Growth During 2020 - Gem Newz - October 9th, 2019
- On creativity, plasticity and repentance - Arutz Sheva - October 5th, 2019
- What's in the cards for this year's Nobel Prizes? - STAT - October 2nd, 2019
- Moving beyond hype: Could one-two treatment restore damaged heart muscle? - University of Wisconsin-Madison - September 28th, 2019
- Conjugated polymers optically regulate the fate of endothelial colony-forming cells - Science Advances - September 28th, 2019
- God of miniscule things - Pune Mirror - September 27th, 2019
- New study shows insight into how cells maintain their identity - Drug Target Review - September 24th, 2019
- Human Embryonic Stem Cells Market: Expansion Strategies Set to Generate Substantial Revenue in the near Future - Rapid News Network - September 24th, 2019
- Global Stem Cells Market 2019 Strategic Assessment by Top Players CCBC, Vcanbio, Boyalife, Beikebiotech - News Coed - September 24th, 2019
- Study Gives Clues to the Origin of Huntington's Disease, and a New Way to Find Drugs - Nature World News - September 24th, 2019
- Global Stem Cells Market 2019 Business Statistics Focus Report Growth by Top Key Players CCBC, Vcanbio, Boyalife, Beikebiotec - The Industry News... - September 24th, 2019
- Orthopedic Biomaterials Product Market Set to Witness YoY Growth by 2018-2026 - NewsStoner - September 24th, 2019
- Global Fetal Bovine Serum Market : Industry Analysis and Forecast (2017-2026) - OnYourDesks - September 24th, 2019
- Stem Cell Therapy Market to Discern Steadfast Expansion During 2020 - Technology Trend - September 24th, 2019
- Embryonic Stem Cell - an overview | ScienceDirect Topics - May 22nd, 2019
- Embryonic Stem Cell Research and Vaccines using Fetal Tissue - May 6th, 2019
- Embryonic Stem Cells - Definitions, Use, and Research - April 28th, 2019
- Will Embryonic Stem Cells Ever Cure Anything? - MIT ... - April 28th, 2019
- Creating Embryonic Stem Cells Without Embryo Destruction - April 23rd, 2019
- What Are Stem Cells? - livescience.com - April 19th, 2019
- Embryonic Stem-Cell Research Reaches Moral, Medical Dead End - April 8th, 2019
- Embryonic Stem Cell: Definition, Uses and Collection ... - April 2nd, 2019
- Advantages of Embryonic Stem Cell Research | Sciencing - March 30th, 2019
- Practical Problems with Embryonic Stem Cells - usccb.org - March 20th, 2019
- Obama Ends Stem Cell Research Ban - CBS News - March 10th, 2019
- Types of Stem Cells A Closer Look at Stem Cells - January 26th, 2019
- Embryonic Stem Cell Research - rtlofneo.com - December 19th, 2018
- The Ethics Of Embryonic Stem Cell Research Viewpoint Essay - December 11th, 2018
- Embryonic Stem Cells and Artificial Stem Cells Are ... - December 5th, 2018
- Embryonic stem cells | Cells | MCAT | Khan Academy - November 25th, 2018
- Crucial Differences Between Non-Embryonic and Embryonic Stem ... - November 23rd, 2018
- 14 Key Pros and Cons of Embryonic Stem Cell Research ... - November 5th, 2018
- Human Embryonic Stem Cells in Development, Volume 129 ... - September 29th, 2018
- Reprogrammed stem cells identical to embryonic stem cells - September 29th, 2018
- Embryonic Stem Cell Protocols by Kursad Turksen | Waterstones - September 29th, 2018
- What Are Stem Cells? Research, Transplant, Therapy, Definition - July 17th, 2018
- Embryonic Stem Cell Research Pros and Cons | HRFnd - June 19th, 2018
- Stem Cell Research: Is It in Danger? - September 29th, 2017
- Truth About Embryonic Stem Cells | Stem Cell Orthopedic ... - September 29th, 2017
- Doubts raised about CRISPR gene-editing study in human embryos - Nature.com - September 2nd, 2017
- Study shows human stem cells restore mobility in Parkinson's monkeys - Borneo Bulletin Online - September 2nd, 2017
- Sofa Vergara's ex might finally be out of luck in his battle for custody ... - Slate Magazine (blog) - September 1st, 2017
- Young cardiac cells rejuvenate heart in animal study - The San Diego Union-Tribune - August 29th, 2017
- embryonic stem cells : NPR - August 25th, 2017
- Mouse model of human immune system inadequate for stem cell studies - Stanford Medical Center Report - August 25th, 2017
- Injections of Vitamin C Could Help Fight Blood Cancer - Wall Street Pit - August 25th, 2017
- Letter: Response to 'Disappointed by Republicans' - The Herald-News - August 20th, 2017
- What are Embryonic Stem Cells? - amaskincare.com - August 19th, 2017
- Woman Will Use Stem Cells From Her Baby's Umbilical Cord To ... - LifeNews.com - August 19th, 2017
- Stem cells mimic sphere where embryos grow - Futurity: Research News - August 19th, 2017
- Vitamin C helps genes to kill off cells that would cause cancer - New Scientist - August 19th, 2017
- A way to stabilize haploidy in animal cells - Phys.Org - August 16th, 2017
- First implants derived from stem cells to 'cure' type 1 diabetes - New Scientist - August 12th, 2017
- Fast facts about cloning - WPSD Local 6: Your news, weather, and sports authority - WPSD Local 6 - August 12th, 2017
- Stem Cell Implant Is Being Trialled To Cure" Type 1 Diabetes - IFLScience - August 12th, 2017
- Lego-Like Brain Balls Could Build a Living Replica of Your Noggin - WIRED - August 12th, 2017
- Amniotic sac in a dish: Stem cells form structures that may aid of infertility research - Phys.Org - August 8th, 2017
- BioTech Marketing and market opportunity for Stem Cells - Checkbiotech.org (press release) - August 8th, 2017
- Stem Cell Training and Top Protocols using Human Umbilical Cell Tissue - Checkbiotech.org (press release) - August 8th, 2017